Solution viscosities (η) and protein–protein interactions (PPI) of three monoclonal antibodies (mAb-A, mAb-B, mAb-C), two bispecific antibodies (BsAb-A/B, BsAb-A/C), and two 1:1 binary mixtures (mAb-A + mAb-B and mAb-A + mAb-C) were measured. mAb-A and mAb-C have similar isoelectric point (pI) values but significantly different η versus protein concentration (c2) profiles. The viscosity of the mAb-A + mAb-C mixture followed an Arrhenius mixing rule and was identical to viscosity of the bispecific BsAb-A/C. In contrast, mAb-A and mAb-B had similar η versus c2 profiles, but the Arrhenius mixing rule failed to predict the higher viscosities of their mixtures. The viscosity of the bispecific BsAb-A/B followed the 1:1 mAb-A + mAb-B mixture at al...
The solution thermodynamics and interactions of a reversibly self-associating IgG1 monoclonal antibo...
The rheological properties of macromolecular and colloidal suspensions are dependent on the thermody...
The viscosity of a monoclonal antibody solution must be monitored and controlled as it can adversely...
The ability to design and formulate mAbs to minimize attractive interactions at high concentrations ...
Solutions of monoclonal antibodies (mAbs) at high concentration are strongly desirable for subcutane...
High concentration subcutaneous (SC) dosing regimens are desirable for monoclonal antibody (MAb) the...
AbstractWeak protein-protein interactions are thought to modulate the viscoelastic properties of con...
The present work investigates the influence of electrostatic surface potential distribution of monoc...
In this study, we used sodium chloride (NaCl) to extensively modulate non-specific protein-protein i...
Coformulations containing two therapeutic monoclonal antibodies (mAbs) could offer various benefits ...
From PubMed via Jisc Publications RouterHistory: received 2021-06-04, revised 2021-07-28, accepted 2...
AbstractSmall-angle neutron scattering (SANS) is used to probe the solution structure of two protein...
For biotechnological drugs, it is desirable to formulate antibody solutions with low viscosities. We...
Using light scattering (LS), small-angle X-ray scattering (SAXS), and coarse-grained Monte Carlo (MC...
High viscosity presents a challenge for manufacturing and drug delivery of therapeutic antibodies. T...
The solution thermodynamics and interactions of a reversibly self-associating IgG1 monoclonal antibo...
The rheological properties of macromolecular and colloidal suspensions are dependent on the thermody...
The viscosity of a monoclonal antibody solution must be monitored and controlled as it can adversely...
The ability to design and formulate mAbs to minimize attractive interactions at high concentrations ...
Solutions of monoclonal antibodies (mAbs) at high concentration are strongly desirable for subcutane...
High concentration subcutaneous (SC) dosing regimens are desirable for monoclonal antibody (MAb) the...
AbstractWeak protein-protein interactions are thought to modulate the viscoelastic properties of con...
The present work investigates the influence of electrostatic surface potential distribution of monoc...
In this study, we used sodium chloride (NaCl) to extensively modulate non-specific protein-protein i...
Coformulations containing two therapeutic monoclonal antibodies (mAbs) could offer various benefits ...
From PubMed via Jisc Publications RouterHistory: received 2021-06-04, revised 2021-07-28, accepted 2...
AbstractSmall-angle neutron scattering (SANS) is used to probe the solution structure of two protein...
For biotechnological drugs, it is desirable to formulate antibody solutions with low viscosities. We...
Using light scattering (LS), small-angle X-ray scattering (SAXS), and coarse-grained Monte Carlo (MC...
High viscosity presents a challenge for manufacturing and drug delivery of therapeutic antibodies. T...
The solution thermodynamics and interactions of a reversibly self-associating IgG1 monoclonal antibo...
The rheological properties of macromolecular and colloidal suspensions are dependent on the thermody...
The viscosity of a monoclonal antibody solution must be monitored and controlled as it can adversely...